Start transitioning adult BCN HMO members using infliximab products to Inflectra®

Starting May 1, 2019, Blue Care Network prefers the infliximab product, Inflectra (infliximab-dyyb), for its adult BCN HMOSM (commercial) members. This change doesn't apply to:

Please refer to the current medical policy for all criteria, and begin taking steps to:

Quick links to helpful resources:

Posted: February 2019
Line of business: Blue Care Network